Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2003
06/10/2003CA2107340C Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
06/10/2003CA2081879C Monoclonal antibodies to polyacrylate polymers
06/05/2003WO2003046576A1 Fibrinogen biopolymer marker and its use for the screening of type ii diabetes
06/05/2003WO2003046575A1 Biopolymer marker indicative of normal human
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046573A2 Protein biopolymer markers predictive of insulin resistance
06/05/2003WO2003046572A2 Biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046571A2 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046570A2 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046569A1 Fibronectin precursor biopolymer marker predictive of alzheimers disease
06/05/2003WO2003046568A2 Protein biopolymer markers indicative of a disease state
06/05/2003WO2003046567A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046566A2 Pedf biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046565A2 Ig lambda biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046564A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046558A2 Complement c3 precursor biopolymer markers predictive of type ii diabetes
06/05/2003WO2003046557A2 Hp biopolymer markers predictive of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046204A2 Humanized collagen antibodies and related methods
06/05/2003WO2003046201A2 Detection and identification of enteric bacteria
06/05/2003WO2003046182A1 Human glioma antigen originating in testis
06/05/2003WO2003046180A2 Human cdnas and proteins and uses thereof
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046009A1 ANTI-IL13 RECEPTOR α1 NEUTRALIZING ANTIBODY
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003046007A2 Treatment of micro-organism infection
06/05/2003WO2003046004A2 Macroglobulin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046003A2 Plasma protease c1 biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046001A2 Protein biopolymer markers predictive of insulin resistance
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045993A2 Protein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045992A1 Cenp-e biopolymer marker indicative of age matched control
06/05/2003WO2003045991A2 Complement c3 precursor biopolymer markers predictive of alzheimers disease
06/05/2003WO2003045989A1 A novel homeobox gene
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045978A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003WO2003045430A1 Tnf-alpha inhibitors for the treatment of hepatic diseases
06/05/2003WO2003045429A2 Anti-t cell immunotoxin fusion protein and its therapeutic use
06/05/2003WO2003045425A1 Muscle transcription factors
06/05/2003WO2003045380A1 Ilk inhibitors for the treatment of renal disease
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045309A2 Peptides, peptide compositions,and methods of use in binding p 185
06/05/2003WO2003045304A2 Mutable vaccines
06/05/2003WO2003045230A2 Novel compositions and methods for cancer
06/05/2003WO2003027288A9 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
06/05/2003WO2002083843A3 Outer membrane associated polypeptides
06/05/2003WO2002081665A3 Implantation serine proteinases
06/05/2003WO2002077261A3 Human potassium channel
06/05/2003WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
06/05/2003WO2002070704A3 Adipocyte complement related protein zacrp11
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060485A3 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002042330A3 Cystoskeleton-associated proteins
06/05/2003WO2002030965A3 Nucleic acids encoding stichodactylidae chromoproteins
06/05/2003WO2002018633A3 Determination of the ability of patients to respond to tumour treatment
06/05/2003US20030106100 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
06/05/2003US20030106096 Phosphonate metabolizing plants
06/05/2003US20030106084 Heat resistant antigen/cd24 fusion proteins; immunoglobulins; autoimmune disorders
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105307 Streptococcus pneumoniale 37-kDa surface adhesion a protein
06/05/2003US20030105303 Primate phagocytic leukocyte protein; detection and diagnosis of immunological disorders; cancer detection
06/05/2003US20030105298 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030105294 Long acting immunnoglobulin polypeptide which binds Fc protection receptors; for use in prophylaxis
06/05/2003US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
06/05/2003US20030105283 Antigenic protein originating in malassezia
06/05/2003US20030105282 Reduced binding affinity for cd4-antigen; immunoassays: vaccines
06/05/2003US20030105060 Synthetic oligomannosides, preparation and uses thereof
06/05/2003US20030105004 Novel morphogenic protein compositions of matter
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104993 Promoting survival of neurons or nerve cells, stimulating cell differentiation, detecting and monitoring neuropathies; a biocompatible tubular casing having openings adapted to receive the ends of a severed nerve, promoting healing
06/05/2003US20030104602 Adipocyte complement related protein zacrp3X2
06/05/2003US20030104601 Chondroitin synthase gene and methods of making and using same
06/05/2003US20030104599 Polypeptide (suv39h2) having histone methyltransferase activity; antitumor agents; meiotic chromatin; contraceptives
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104561 For stimulating tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis
06/05/2003US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104549 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104545 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104544 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104535 Adheson variants
06/05/2003US20030104523 Process for high throughput screening of CpG-based immuno-agonist/antagonist
06/05/2003US20030104516 Protein kinase npk-110
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104497 Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis
06/05/2003US20030104488 Amyloid protein for use in treatment of nervous system disorders
06/05/2003US20030104485 Antibodies specific for osteoprotegerin binding proteins and method of use
06/05/2003US20030104482 Death associated kinase containing ankyrin repeats (DAKAR)
1 ... 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 ... 1494